The number of people with susceptibility test result for rifampicin in Jamaica
Jamaica: The number of people with susceptibility test result for rifampicin was 44 in 2021. ▲ Rising
Latest (2021)
44
Change on year
up 18.9%
World rank
124th
of 155 countries
All-time high
49
in 2019
All-time low
16
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Jamaica, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Jamaica stood at 44.
The figure is up 18.9% on the previous year and up 175.0% over five years.
Jamaica ranks 124th of 155 countries on this measure, in the bottom quarter.
The number of people with susceptibility test result for rifampicin in Jamaica, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 16 | — |
| 2018 | 45 | +181.2% |
| 2019 | 49 | +8.9% |
| 2020 | 37 | -24.5% |
| 2021 | 44 | +18.9% |
Jamaica compared with similar countries
- Jamaica's 44 is below the median for upper middle income countries, which is 880, 5% of the median. (46 countries reporting)
- Jamaica's 44 is below the median for Latin America & Caribbean, which is 406.5, 11% of the median. (26 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 36.67 | 16 | 49 | 3 |
| 2020s | 40.5 | 37 | 44 | 2 |
Countries ranked near Jamaica
More health data for Jamaica
- Un projection of annual infant deaths, annual growth rate -3.12 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.3325 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 2,308 deaths per 1,000 people (2090)
- Number of infants who die before age 1 31 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -1.64 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0278 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.6 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Jamaica?
- The number of people with susceptibility test result for rifampicin in Jamaica was 44 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Jamaica?
- The highest recorded value was 49 in 2019.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Jamaica?
- The lowest recorded value was 16 in 2017.
- How does Jamaica rank for the number of people with susceptibility test result for rifampicin?
- Jamaica ranks 124th out of 155 countries with data for 2021.
- Where does this Jamaica data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).